"Nootropic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.
| Descriptor ID |
D018697
|
| MeSH Number(s) |
D27.505.954.427.637
|
| Concept/Terms |
Nootropic Agents- Nootropic Agents
- Agents, Nootropic
- Nootropics
- Cognitive Enhancers
- Enhancers, Cognitive
- Nootropic Drugs
- Drugs, Nootropic
|
Below are MeSH descriptors whose meaning is more general than "Nootropic Agents".
Below are MeSH descriptors whose meaning is more specific than "Nootropic Agents".
This graph shows the total number of publications written about "Nootropic Agents" by people in this website by year, and whether "Nootropic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 0 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 7 | 2 | 9 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Nootropic Agents" by people in Profiles.
-
Maternal choline and respiratory coronavirus effects on fetal brain development. J Psychiatr Res. 2020 09; 128:1-4.
-
Neurodegenerative Disease Mortality among Former Professional Soccer Players. N Engl J Med. 2019 11 07; 381(19):1801-1808.
-
Exploring cocoa properties: is theobromine a cognitive modulator? Psychopharmacology (Berl). 2019 Feb; 236(2):561-572.
-
Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action. J Cell Physiol. 2019 06; 234(6):8496-8508.
-
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med. 2018 09; 15(9):e1002660.
-
Changes in electrophysiological markers of cognitive control after administration of galantamine. Neuroimage Clin. 2018; 20:228-235.
-
Diagnosing and treating dementia in German primary and specialized care between 2011 and 2015?. Int J Clin Pharmacol Ther. 2018 Jul; 56(7):301-309.
-
Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials. Clin Pharmacol Ther. 2019 01; 105(1):121-130.
-
Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs. Int J Mol Sci. 2018 Feb 03; 19(2).
-
Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease. Curr Drug Metab. 2018; 19(8):704-713.